Instil Bio, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 18.66 million compared to USD 58.99 million a year ago. Basic loss per share from continuing operations was USD 2.8 compared to USD 9.2 a year ago.
For the six months, net loss was USD 75.73 million compared to USD 113.11 million a year ago. Basic loss per share from continuing operations was USD 11.6 compared to USD 17.6 a year ago.